Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEGGN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,696
Award facts
- Contract value 100% obligated
- $44,695.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,695.87 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations on August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and is classified as a child contract under a larger indefinite delivery vehicle. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025.
This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Cosentyx, a specialty medication used in the treatment of autoimmune conditions, supports the Defense Health Agency and broader military healthcare system requirements. AmerisourceBergen's award demonstrates its capability to meet federal procurement standards through open competition and reflects the company's established role as a critical pharmaceutical distributor for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FEGGN?
SPE2DB25FEGGN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FEGGN worth?
The government has obligated $44,696 on SPE2DB25FEGGN.
Is contract SPE2DB25FEGGN an order under another contract?
Yes. SPE2DB25FEGGN is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGGN competed?
The extent of competition for SPE2DB25FEGGN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award